What Is Assort Health and What Does It Do?
Here is the thing about healthcare. It is broken in a way most people do not notice until they are sitting on hold for 45 minutes trying to book a specialist appointment. Assort Health noticed. And they decided to fix it from the very beginning of the patient experience, not from somewhere in the middle.
Founded in 2023 by Co-CEOs Jon Wang and Jeffery Liu, Assort Health is a San Francisco-based company that automates the entire patient journey. Scheduling. Intake forms. Referrals. Medication refills. Lab requests. Real-time insurance eligibility checks. Payments. Every single touchpoint a patient encounters before they actually see a doctor is on the table.
The reality is, most people do not understand the scale of how broken this system actually is. Healthcare providers in the US spend nearly twice as much on administration as they do on direct patient care. That is not a rounding error. That is a $1.1 trillion annual administrative burden sitting on top of the entire healthcare industry, and almost none of it is being handled with any real intelligence.
What Assort built is fundamentally different from every other automation tool that came before it. The difference comes down to memory. Most platforms treat every patient call as if that patient never existed before. Every interaction starts cold. Assort maintains a continuous record across every interaction, every channel, and every visit. The moment a patient calls in, the system already knows their insurance history, their medication preferences, their previous clinical alerts. It does not start over. It picks up exactly where it left off.
That might sound like a small detail. In healthcare, it changes everything.
Assort Health Raises $120M Series C Led by Menlo Ventures
On June 24, 2026, Assort Health closed a $120M Series C led by Menlo Ventures. The deal values the company at $1.2 billion. JP Sanday, Partner at Menlo Ventures, is joining the Board of Directors. Matt Murphy, also a Menlo Partner, is serving as a Board Observer.
Let’s be honest. When Menlo Ventures leads a round, people pay attention. This is the same firm that backed Anthropic. Murphy made their thesis clear after that investment: find the best application-layer companies in every category. For healthcare administration, Assort Health raised $120M as the firm’s definitive answer to that thesis.
And the logic holds up when you see how the platform compounds. Every patient interaction makes the system sharper. Every edge case it resolves gets folded back into the model. The value does not plateau. It accelerates.
The capital goes toward deeper integrations with EHR systems including Epic and Athena, expanding the engineering team, and pushing the platform aggressively into large enterprise health systems across the country. This is not maintenance capital. It is growth capital with a clear direction.
Assort Health Is Now Valued at $1.2 Billion
Unicorn status. Three years old. Let that sit for a second.
The $1.2 billion valuation is not hype. It is a direct reflection of the data advantage Assort has spent three years carefully constructing. The company is sitting on 190 million patient voice interactions, 62,000 care protocols, and 1.6 million distinct decision pathways. That is the largest proprietary specialty healthcare dataset in existence right now.
No one is replicating that in a year. Or two. General-purpose AI models cannot compete with it, because they were not trained on the specific, high-stakes, specialty-level complexity of real healthcare workflows. Assort was. Specialty by specialty. Practice by practice. Edge case by edge case.
Here is the kicker. That dataset compounds entirely on its own. Every new provider that joins the platform adds to it. Every new health system makes it stronger. The moat does not require active maintenance. It widens by default as the business grows.
And the broader market shift is visible too. Healthcare AI is moving fast toward consolidation. The era of isolated point solutions, one tool for scheduling, a different one for intake, another for referrals, is ending. Providers are tired of managing five vendors to solve one patient journey. Assort Health raised $120M to be the platform that replaces all of them.
Who Are the Investors Behind This $120M Round?
Menlo Ventures led. But the rest of the cap table is worth paying attention to.
Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Tau Ventures, and Quiet Capital all returned for this Series C. Joe Montana joined as a new investor this round as well.
Assort Health has now raised more than $222 million in total since founding in 2023. But the pace is what stands out more than the total. $26M Series A in April 2025. $76M Series B led by Lightspeed Venture Partners in September 2025. And now $120M Series C only nine months later. Three rounds. Each one larger than the last. All within 15 months of each other.
This is not a company barely convincing investors to stay in. This is a company where investors are actively trying to maintain their allocation. That is a very different energy, and anyone who has spent time raising money knows exactly what that difference feels like.
How Assort Health’s AI Platform Works for Patients
Four products. One memory layer. That is the architecture in plain terms.
Concierge handles all inbound patient calls, intelligent clinical triage, multilingual appointment scheduling, lab coordination requests, and insurance-related questions. Activate runs outbound patient engagement, closing open referral loops, recovering missed appointments, following up on care gaps, and collecting outstanding payments before they fall off the radar. Orchestrate automates the operational workflows surrounding patient visits and pushes structured data directly into EHR and practice management systems without requiring any manual entry. Empower provides clinical and administrative staff with real-time AI tools to manage patient access and complex operational workflows without switching between systems.
All four sit on top of Patient Journey Memory. The continuous, cross-channel record that makes real personalization possible at real scale. Every interaction adds to it. Nothing gets lost.
And then there is Synapse. Assort’s proprietary AI model, trained on those 190 million patient interactions, 62,000 care protocols, and 1.6 million distinct decision pathways. It does not just respond to patient requests. It continuously generates edge cases, runs internal simulations, and stress-tests its own responses before anything unusual ever reaches a live patient interaction. When something genuinely complex comes in, it does not break down. It adapts.
So the real product is not a chatbot. Not a voice bot. It is a system that learns exactly how your specific practice operates and gets measurably better at running it every single week.
Assort Health Revenue Grew 20x in Just 15 Months
Here is the number that stops every conversation cold. 20x revenue growth in 15 months.
In healthcare. A market historically defined by slow procurement cycles, endless compliance reviews, procurement committees, and deep institutional resistance to changing anything. 20x.
The customers are not quiet about the results either. Dr. Parinita Amin, CEO of MDCS Dermatology, put it directly. Her team evaluated every AI solution available on the market. Assort Health was the only true platform. Not a point solution solving one workflow and leaving the rest broken, but a connected system running the full patient journey in a single, continuous operation. Her automation rate climbs every quarter without anyone manually intervening to make it happen.
Jon Shaker of the Boston Bone and Joint Institute said the same thing from a different angle. Everyone else automates one piece and forgets the rest. Assort remembers every patient across every single interaction.
But here is what the 20x number actually tells you. This growth did not come from aggressive discounting or a hyperactive sales team making promises the product could not keep. It came from building specialty by specialty, practice by practice, solving the exact edge cases that generic AI systems repeatedly failed on. The result is a data and performance moat wide enough to carry a $1.2 billion valuation without anyone raising an eyebrow.
Assort Health Plans to Expand Into Major Health Systems
Until now, Assort’s core customers have been multi-site specialty practices. That chapter is not closing. But the next one is significantly larger.
With the $120M, Assort Health is going after enterprise health systems. Large community-based organizations. Academic medical centers. John Muir Health has already signed on as a partner, and more are expected to follow as the commercial expansion picks up pace.
Moving into full health systems is not just doing the same thing at a larger scale. The workflows are more complex. The patient volumes are far higher. The margin for operational error is essentially zero. Regulatory scrutiny is tighter. And the stakes attached to every automation decision are much bigger.
Assort Health believes Synapse was built for exactly that environment. As Jeffery Liu stated in the Series C announcement, specialty care is a different discipline than most AI vendors realize, and that difficulty compounds at large health systems. Synapse learns the specific patterns of those workflows and gets sharper with every new deployment. Not in theory. In practice.
So here is where Assort Health stands right now. $222M in total funding. $1.2 billion valuation. 190 million patient interactions processed. 20x revenue growth in 15 months. And a market that is only beginning to consolidate around the platforms that can run the full patient journey without dropping the thread.
The $120M Series C is not just a fundraising milestone. It is a clear statement about who is building the infrastructure layer for AI-powered healthcare in America. And for now, that answer is Assort Health.
Sources used in this article:
Read about – Startup business models
Read in – Startup Directory
Read about Solo businesses
Hi Friends, This is Swapnil; I love reading and sharing knowledge. Currently working as a content writer at startupsunion.com. You all can hang out with me here.